The relationship between the serum factor(s)-mediated induction of low-density lipoprotein (LDL) mRNA, reaching a maximum of 5-10-fold by 2 h and decreasing to near baseline levels by 4 h. Actinomycin D blocked the serum-factor-mediated induction of LDL receptor mRNA. These data indicate that LDL receptor gene expression in liver-derived cells is rapidly and transiently increased by incubation with a factor(s) present in serum and that this induction is independent of demonstrable changes in cellular cholesterol metabolism.
INTRODUCTION
The level of plasma low-density lipoprotein (LDL) cholesterol is a major risk factor for the development of atherosclerosis [1] . The level of LDL cholesterol in the blood is maintained by a dynamic balance between the formation and catabolism of LDL. Although many organs can participate in LDL removal, the liver is the most important single site, and the majority of this uptake is mediated by the LDL receptor [2] [3] [4] [5] [6] [7] . The factors that determine the number of LDL receptors expressed by the liver are not completely understood. The principal form of LDL receptor regulation demonstrated to date is by feedback, where increasing cellular cholesterol content causes a decrease in the number of cell surface LDL receptors [8] . Thus incubation of a variety of cells in the presence of LDL, cholesterol or oxygenated sterols results in a decrease in LDL receptors, an effect mediated by a decrease in transcription of the LDL receptor gene [8] . Recent studies on the mechanism of sterol-dependent regulation of LDL receptor activity have focused on a 42 bp sequence, termed the sterol regulatory element (SRE), in the 5'-flanking region of the LDL receptor gene [8] [9] [10] [11] . This sequence contains two contiguous 16 bp imperfect repeats that differ in their mode of regulation.
Repeat number 3 is a constitutive positive transcriptional element that binds the eukaryotic transcription factor Spl, while repeat number 2, which has the sequence CACCCCAC, designated SRE-1 [8] , is thought to interact with another regulatory protein to confer strong repression upon repeat number 3 when sterols are present [11] . Although mutation of SRE-1 leads to a loss of sterol-dependent regulation, mutation of SRE-1 in the LDL receptor promoter also prevents the increase in transcription that occurs in the absence of sterols [10] . Thus, in the LDL receptor promoter, SRE-1 appears to contain the signals for positive and negative regulation by sterols. While it appears that this type of control may be important for sterol-mediated repression of the LDL receptor promoter, it is not clear whether these cis-acting transcriptional elements are responsible for all forms of LDL receptor regulation.
Over the last few years evidence, both direct and circumstantial, has accumulated that supports the occurrence of the regulation of LDL receptors independent of cellular sterols. In both adrenal [12] [13] [14] and ovarian granulosa [15] [16] [17] cells, LDL receptor activity is increased in response to hormone administration and occurs under conditions in which the cholesterol demand for steroidogenesis is low and LDL receptors should be down-regulated.
Abbreviations used: VLDL, very-low-density lipoprotein; ,-VLDL, VLDL that migrates with ,l electrophoretic mobility on agarose gel electrophoresis; LDL, low-density lipoprotein; HDL, high-density lipoprotein; MEM, Eagle's minimal essential medium; EBSS, Earle's balanced salt solution; PBS, phosphate-buffered saline; HMG, 3-hydroxy-3-methylglutaryl; SRE, sterol regulatory element; PDGF, platelet-derived growth factor; ASGR, asialoglycoprotein receptor.
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Furthermore, regulation of LDL receptor activity in the outer (glomerulosa and fasiculata) and inner (reticularis) zones of the adrenal cortex is different. In general, in the outer zone hormonal modulation of steroid hormone production is linked to changes in LDL receptor activity, while in the inner zone adrenocorticotrophic hormone and dexamethasone regulate cholesterol metabolism, but do not significantly affect LDL receptor activity [13] .
The expression of LDL receptors by cells in culture is also affected by a variety of incubation conditions. Receptor activity is increased by incubation of cells with insulin [18] [19] [20] , plateletderived growth factor (PDGF) [21] [22] [23] [24] , fibroblast-derived growth factor [21] , thyroid hormone [20, 25] , oestrogen [26] , Ca2l channel blockers [27] [28] [29] and calmodulin inhibitors [30] [31] , and by factors present in serum [32] . It is not clear whether the effects of these growth-related factors on LDL receptor activity in the various cell types are secondary to changes in cellular cholesterol content or whether they act as primary effectors. However, conditions have been described for some of these agents in which the increase in LDL receptor activity appears to be independent of the content of or demand for cellular cholesterol.
Regulation of cholesterol metabolism is more complex in liver cells than in less specialized cells such as skin fibroblasts. In the liver, newly synthesized cholesterol, or that derived from the catabolism of lipoproteins, can be used for bile acid synthesis, secreted as biliary cholesterol or used for lipoprotein production, in addition to supplying cholesterol for the formation of cell membranes [3] . Interestingly, relative to regulation of LDL receptors in fibroblasts, the LDL receptor activity of Hep-G2 cells [33] [34] [35] [36] , pig [37] , rat [38] and human hepatocytes [39] [40] [41] is somewhat resistant to down-regulation by cholesterol derived from exogenous LDL. In general, an extracellular concentration of LDL that produces an 80-85 % decrease in LDL receptor number in fibroblasts [33, 42] [32] . Furthermore, serum factor stimulation of 1251I-LDL uptake appeared to be specific for LDL receptors in Hep-G2 cells as compared with human skin fibroblasts, and the induction of LDL receptor activity appeared to occur in the absence of changes in cellular cholesterol biosynthesis. These data suggested that a serum component may be responsible for sterol-independent regulation of hepatic LDL receptor activity. The Very-low-density lipoproteins with , electrophoretic mobility (fl-VLDL) from hypercholesterolaemic rats were isolated as described [44] . The lipid and apoprotein composition of these particles has been reported previously [44] . To 4°C , sterilized and stored as described above.
Asialo-orosomucoid was prepared and iodinated by the chloramine-T procedure as described previously [32] . The specific radioactivity of the 125I-asialo-orosomucoid was 2600 c.p.m./ng of protein, and more than 95 % of the radioactivity was precipitable by an equal volume of 20% trichloroacetic acid. The specific uptake of 125I-asialo-orosomucoid, determined in the presence and absence of a 100-fold excess of unlabelled asialoorosomucoid, was always greater than 90 % of the total.
Lipoprotein binding studies
Hep-G2 cells were seeded into 6-or 12-well tissue culture plates at a density of (1-2) x 105 cells/cm2 (day 0) and were grown in medium A as described above. By day 3 or 4 the cells had formed dense monolayers of 4.5 x 105 cells/cm2 and 0.1 mg of cell protein/cm2. The cells were placed on ice, the medium was removed and the monolayers were washed once with 2-4 ml of ice-cold Earle's balanced salt solution (EBSS) containing 0.02 MHepes, pH 7.4. The washes were discarded and each dish received fresh MEM containing 292 ,ug of glutamine/ml with either no additions (MEM control), 15 % (v/v) dialysed calf serum (MEM + serum) or 15 % (v/v) d> 1.25 fraction of calf serum (MEM + d > 1.25). The cells were returned to the incubator, and after the indicated time (generally 5-6 h) the incubation media were removed and the cells were placed on ice and washed. The cells were then incubated with the indicated concentration of 125I-LDL in 0.4 ml (for 12-well plates) of medium B (MEM containing 0.02 M-Hepes, pH 7.4, and 40 mg of BSA/ml). Incubations at 37°C were started by the addition of the incubation mixture to the cells and terminated by placing the cells on ice. The binding media were removed and the cells were washed as described [32] . The cells were solubilized with 1.0 ml of 1.0 M-NaOH and the cell-associated radioactivity was determined. The uptake of 1251I-LDL was determined in the presence (non-specific uptake) and absence (total uptake) of a 100-fold excess of unlabelled LDL. The specific uptake was calculated as the difference between the total and non-specific values, and represented about 80 % of the total. Unless specified otherwise, the specific uptake of 125I-LDL is presented in the Tables and  Figures. The measured radioactivity was normalized per mg of cell protein, which was determined in an aliquot of the cell suspension. Human skin fibroblasts were cultured and used in lipoprotein binding studies as described previously [32] .
Cholesterol loading of Hep-G2 cells
Hep-G2 cells were cholesterol-loaded by incubation with ,-VLDL isolated from hypercholesterolaemic rats as follows. On day 3 or 4 of culture, the medium was removed from each dish of cells, the cell media were combined and any cellular debris was removed by centrifugation at 1000 g for 10 min at 4 'C. An aliquot of the conditioned media pool was added to each dish of cells, /f-VLDL was added in the indicated amounts to the appropriate dishes and the cells were returned to the incubator. After 18-24 h at 37 'C the cells were removed from the incubator and placed on ice. The cell media were removed and the cells were washed with ice-cold EBSS + 0.02 M-Hepes, pH 7.4 To measure the incorporation of radiolabelled precursors into cellular lipids, Hep-G2 cells were cultured in 6-well plates as described above, and on day 3 or 4 the cell media were removed and the cells were washed with 2 (15 ,ug) , ubiquinone (30,ug) , squalene (10,ug) and cholesteryl oleate (75 tg) was added as standard. The lipids were dried under N2 and separated by t.l.c. on silica gel G plates using the two-dimensional solvent system as described [45] . The 37 'C the cells from each experiment were placed on ice and the media were removed and centrifuged for 2 min in a Microfuge and were extracted immediately or stored at -20 'C before extraction for total lipids as described above. Each dish of cells was washed with 2 ml of ice-cold PBS and the cells were scraped from the dish into 1 ml of ice-cold PBS. The cells were centrifuged at 1000 g for 5 min and were resuspended in a small volume of ice-cold PBS. A sample was removed for protein determination and the remainder was extracted for total lipids as described above. The lipid extracts were dried under N2 and the radioactivity in unesterified and esterified cholesterol was determined by t.l.c. on silica gel G using the single dimension system as described above.
Measurement of cell cholesterol mass
Hep-G2 cells were subcultured in T-25 flasks at a density of 2 x 105 cells/cm2. On day 3 the cell media were removed and the cells were washed. Each flask of cells received 3 ml of MEM containing no additions, 15 % serum or the d > 1.25 fraction of serum. After incubation for 5 h at 37°C the media were removed, the cells were washed with 2 ml of ice-cold PBS and the cells were scraped from the dishes into 1 ml of ice-cold PBS. The cells were then centrifuged at 1000 g for 5 min and either extracted immediately for total lipids as described above or quick-frozen in liquid N2 and stored at -20°C until used. The cellular mass of cholesterol was measured by gas chromatography on 3 % SP-2250 on 80/100 Supelcoport as described previously [32] .
Isolation and quantification of mRNA Total cellular RNA was isolated from Hep-G2 cells by the single-step guanidinium thiocyanate procedure [46] , and poly(A)+ RNA was selected by chromatography on oligo(dT)-cellulose according to standard procedures [47] . RNA samples were further assessed by Northern blot and slot-blot hybridization (see below). clone pSAl [50] was used to detect ASGR mRNA. Inserts were excised from the plasmids with the appropriate restriction enzymes and were extracted from 1 % low-melting agarose gels using the hexadecyltrimethylammonium bromide procedure [51] and were labelled with [32P]dCTP to a specific radioactivity of (0.5-1.0) x 109 c.p.m./,ug by random priming with Klenow Preparation of cell membranes and their solubilization A 500-105 000 g cell membrane fraction was prepared from Hep-G2 cells and solubilized with CHAPS exactly as described previously [52] . For each incubation condition, seven T-75 flasks containing approx. 3 x 108 cells were used. Immunoblotting with anti-(rat liver LDL receptor) antibodies Samples of detergent-solubilized membranes (25-100 ,g of protein) were adjusted to final concentrations of 0.002 % (w/v) Bromophenol Blue, 0.5 % (w/v) SDS and 13 % (w/v) glycerol and were applied to 6 % polyacrylamide gels containing 0.1 % (w/v) SDS under non-reducing conditions as described previously [52] . Gels were calibrated with a 15 ,l sample of the Rainbow Protein Molecular Weight Markers containing myosin (200 kDa), phosphorylase b (92.5 kDa), BSA (69 kDa), ovalbumin (46 kDa), carbonic anhydrase (30 kDa), trypsin inhibitor (21.5 kDa) and lysozyme (14.3 kDa) . Proteins were electrophoretically transferred to nitrocellulose paper as described previously [52] . Immunoblotting was carried out as described [52] , except that incubations with the anti-(rat liver LDL receptor) antiserum and the horseradish peroxidaseconjugated goat anti-rabbit IgG were extended to 3 h and 2 h respectively. Immunoblots were developed with 4-chloro-1-naphthol as described [52] and the amount of LDL receptor protein was quantified by scanning densitometry of the dried membrane.
Other methods Cellular and lipoprotein protein was measured with the BioRad (Richmond, CA, U.S.A.) protein assay kit using BSA as standard. The total cholesterol content of the lipoproteins was measured enzymically with the Cholesterol 20 kit (Sigma). Statistical analyses were performed using a paired or unpaired two-tailed Student's t-test or by analysis of variance.
RESULTS
Kinetics and specificity of the serum-mediated induction of LDL receptor activity in Hep-G2 cells
In a previous study [32] we noted that the number of cell surface LDL receptors in Hep-G2 cells increased during 24-48 h of incubation with serum or a partially purified fraction of serum. Further, in incubations of 8 h or less, the serum-mediated increase in 125I-LDL uptake occurred in the absence of changes in cholesterol biosynthesis. This suggested that the change in LDL receptors occurred independently of changes in cell sterol metabolism. To further explore this, the kinetics of induction of LDL receptor activity were examined in greater detail. When Hep-G2 cells were incubated in the absence of serum (MEM control) there was little change in 1251I-LDL uptake over this time course (Fig. la, 0) . In contrast, after a lag of approx. 2 h, incubation with MEM + 15 % calf serum (MEM + serum) produced a time-dependent increase in cell-associated 125I-LDL (Fig. la, *) . The serum-mediated increase in 1251I-LDL uptake was also dependent on the concentration of serum used in the incubation. The uptake of 125I-LDL increased in a dose-dependent manner to a maximum of 2.3-fold at a serum concentration of 20% (Fig. lb) . Addition of higher concentrations of calf serum, up to 80 %, did not increase the uptake of 12511 LDL beyond this level. Similar to our previous results [32] , incubation with MEM+serum had no significant effect on the amount of cell protein per dish (results not shown).
To evaluate whether the induction of 125I-LDL uptake was specific for transport through the LDL receptor pathway, the ability of anti-(rat liver LDL receptor) antibodies [531 to compete for uptake of125I-LDL was determined. The anti-(LDL receptor)
Vol. 279 antibodies were as effective as unlabelled LDL in competition for 1251I-LDL uptake in serum-stimulated cells (Fig. 2a) . Furthermore, the uptake of 1251-methyl-LDL was not increased by incubation in the presence of serum-containing medium (Table  1 ), indicating that incubation with MEM +serum had no effect on the LDL-receptor-independent uptake of 1251-LDL. Immuno Hep-G2 cells Hep-G2 cells were subcultured in 12-well plates as described in the Experimental section. (a) On day 3 the culture media were removed, the cells were washed and a 0.5 ml sample of MEM or MEM + 15 % calf serum, prewarmed to 37°C, was added to the appropriate dishes of cells. After incubation for the indicated period of time at 37°C, the cells were placed on ice, the media were removed, the cells were washed and each dish was incubated with 1251I-LDL ( (Fig. 3) . In contrast, after a lag of approx. 2-3 h, incubation with MEM +serum produced a time-dependent in- These data indicate that the serum-factormediated increase in HMG-CoA reductase activity may be due to a requirement for another mevalonate-derived product.
To explore this, the effect of the serum factor on [14C]acetate flow through the isoprenoid pathway was determined. Hep-G2 cells were incubated with [14C]acetate for 1 h at 37°C and MEM, MEM + serum or MEM + d > 1.25 were added for an additional 5 h at 37°C, and radiolabel incorporation into total cell protein and two other products of mevalonate metabolism, dolichol and ubiquinone, was determined. In addition, radiolabel incorporation into the two major intermediates in the sterol pathway, squalene and lanosterol, was quantified. Relative to incubation with MEM alone, incubation with MEM + serum or MEM + d > 1.25 had no effect on radiolabel incorporation into total cell protein or into any of the isoprenoid compounds examined (results not shown). Of the total non-saponifiable lipids, 80-90 % of the radioactivity on average was recovered in cholesterol, with the balance recovered in squalene and lanosterol. After 2 h at 37 'C the specific cell-associated '25I-LDL was determined as described in the Experimental section. The values represent means + S.D. of measurements on triplicate dishes and are representative of two separate experiments. Significant differences from MEM control: *P < 0.02, **P < 0.001, ***P < 0.006. (b) For each incubation condition the data in (a) were normalized to the amount of cell-associated '25I-LDL measured in cells incubated with MEM. Significant differences from the zero fl-VLDL control:
*P < 0.003; **P < 0.03. Where not shown, the error bars are contained within the symbols.
esterol esters ( Effect of incubation with MEM +serum on LDL receptor and HMG-CoA reductase activities in cholesterol-loaded cells It has been reported that LDL receptor activity in primary cultures of human [39] [40] [41] , rat [38] and pig [37] hepatocytes and Hep-G2 cells [33] [34] [35] [36] is relatively insensitive to changes in cell cholesterol content as compared with human skin fibroblasts. To determine if the serum-mediated induction of 125I-LDL uptake in Hep-G2 cells is sensitive to changes in the cellular content of Vol. 279 (Fig. 4a) . However, compared with incubation with MEM alone, incubation with MEM +serum stimulated 125I-LDL uptake in the cholesterolloaded cells. Since the basal activity was lower, the relative increase in 125I-LDL uptake was actually greater than in the control cells (Fig. 4b) , although the absolute increase was modestly lower. Similarly, cholesterol loading decreased the activity of HMG-CoA reductase in Hep-G2 cells incubated with either MEM or MEM+serum (Fig. 5a) . However, the serummediated increase in HMG-CoA reductase activity was also Furthermore, the serum-factor-mediated increase in LDL receptor mRNA was blocked by incubation of the cells with actinomycin D (Fig. 7) . In contrast, relative to the level of ,-actin mRNA, actinomycin D had little effect on the level of ASGR mRNA (Fig. 7, A) . Taken together, these data indicate that the serum-mediated induction of LDL receptor activity is due to an increase in the accumulation of LDL receptor mRNA.
relatively unaffected by cholesterol loading (Fig. 5b ). In the past, most examples of regulation of LDL receptor activity could be ascribed to changes in cellular cholesterol metabolism [1] . For instance, in cultured cells incubated in media containing whole serum, LDL receptor expression represents a balance between at least two opposing factors that regulate the cell cholesterol balance: the lipoprotein (VLDL + LDL)-induced suppression and the HDL-mediated induction of LDL receptor gene transcription. HDL and VHDL and other cholesterol acceptors can induce LDL receptor activity by promoting cholesterol efflux [54, 55] . In the present study an increase in the amount of radiolabelled cholesterol present in the cell media with cells incubated in the presence of whole serum was observed. Interestingly, this occurred without a change in the mass of cellular cholesterol, indicating that even after 22 h of incubation the [3H]mevalonate-labelled pool in Hep-G2 cells is not in equilibrium with total cellular pool of cholesterol. The efflux of cholesterol was due to the presence of HDL, since it was eliminated by removal of the d = 1.063-1.25 lipoproteins. However, an HDL-induced decrease in cellular cholesterol does not appear to be responsible for the serum-factor induced LDL receptor activity, since induction of 1251I-LDL uptake was not diminished by the use of the d > 1.25 fraction of serum that did not promote efflux. These data are consistent with our previous report [32] where we observed that incubation of Hep-G2 cells with the HDL fraction (d = 1.063-1.210) of human serum did not increase the total processing of 125I-LDL. Finally, since Hep-G2 cells synthesize and secrete lipoproteins [56] , a portion of the radiolabelled cholesterol entering the medium is probably due to lipoprotein secretion. Thus the conclusion that the stimulatory effect of the serum factor on LDL receptor activity is not due to enhanced cholesterol efflux appears to be sound.
When a cell is induced to grow, particularly in preparation for cell division, new membranes must be synthesized, and this requires additional cholesterol. This could result in the movement of cholesterol from some regulatory internal pool to the membrane and thus stimulate LDL receptor activity. Such a process cannot be completely excluded in the present study, since it has not been possible to identify or isolate this putative regulatory pool of sterol. However, several of our findings argue against this sequence of events. First, there was little evidence of cell growth during the time course of these studies, as demonstrated by the lack of change in cell number, protein content, DNA synthesis [32] , ASGR activity or level of mRNA for ,J-actin. As reported previously [32] , however, with longer-term incubations (24-48 h) some of these parameters did ultimately change, consistent with the concept that the serum factor is inducing cell growth.
Secondly, in the present study no changes were observed in cellular cholesteryl ester metabolism. In general the cellular cholesterol ester pool changes rapidly in concert with other changes in cholesterol metabolism [57] . Finally, when the cells were preloaded with a large amount of cholesterol the induction of LDL receptor activity by the serum factor still occurred, although the magnitude of 125I-LDL uptake was somewhat diminished. Thus the most simple hypothesis is that, in response to a stimulus that initiates the process of cell growth, there is activation of a group of genes that provide the necessary materials for cell growth and replication, and this begins before there is an actual depletion or shortage of the material, presumably in this case cholesterol.
This hypothesis is also consistent with our observations that HMG-CoA reductase activity was stimulated by incubation with the serum factor, even though cholesterol synthesis was not increased over the time period of these experiments. Further, the induction of HMG-CoA reductase activity also occurred in cholesterol-loaded cells. Most probably, the additional mevalonate being generated may be used for the biosynthesis of non-sterol isoprenoids that are now recognized to be critical for cell replication, particularly isoprenylated proteins (such as p21 ra8 proteins) and others (such as the nuclear membrane protein lamin B) [8] A number of other examples of regulation of LDL receptor activity that may not be preceded by a change in sterol content using cultured human granulosa cells, have been published [16, 59] . In addition, Cuthbert and co-workers [60, 61] reported that the early induction (< 2 h) of LDL receptor gene transcription in lymphocytes by incubation with lipoprotein-deficient serum was independent ofprotein synthesis and was not regulated by exogenous sterols. In contrast, continued LDL receptor gene transcription detected after longer (24 h) incubations in the absence of sterols required ongoing protein synthesis and gene transcription, and was down-regulated by exogenous sterols. Taken together, these findings and those of the present study indicate that factors other than cellular sterols may also regulate LDL receptor gene expression.
Factors such as platelet-, endothelial cell-and fibroblastderived growth factors produce a time-dependent stimulation of DNA synthesis, cholesterol synthesis and LDL receptor activity in cultured human fibroblasts and vascular smooth muscle cells [21] [22] [23] [24] . In some instances the induction of LDL receptors appears to be independent of changes in cholesterol metabolism; for example, PDGF can stimulate LDL receptor activity in the presence of high extracellular concentrations of LDL [23, 24] and in the absence of measurable changes in cellular cholesterol biosynthesis [23] . However, recent evidence [62] from studies of LDL receptor activity in PDGF-stimulated fibroblasts transfected with plasmids bearing a portion of the LDL receptor gene 5'-flanking sequence from -76 to -35 suggests that growth factor induction of LDL receptor protein abundance and gene transcription is mediated by this region, which also modulates the response to a change in cell sterol balance. In preliminary studies (J. L. Ellsworth & A. D. Cooper, unpublished work) we have excluded PDGF, basic fibroblast growth factor, insulin, insulin-like growth factors-I and -II, transferrin, thrombin, 17,8-oestradiol and tri-iodothyronine as the modulator of the serum factor effect we are describing.
In the liver, hormones such as insulin, thyroxine and oestrogen increase LDL receptor activity [19, 20, 26] . The induction of hepatic LDL receptors by oestrogen occurred under conditions in which the liver content of cholesteryl ester was increased 2- fold and the non-esterified and esterified cholesterol content of liver plasma membranes was increased by 130 % and 400 % respectively [63, 64] another sterol which then mediates transcription by the mechanism previously described for sterols [8] . Alternatively, there may be another mediator(s) which affects the LDL receptor and HMG-CoA reductase genes directly. This could occur at the same cis-acting regulatory sites as the sterol-mediated effect, such as SRE-1 [8] , or it could occur at novel sites. In this regard, it is important to note that a number of other genes, such as c-fos [65] , respond to serum and/or growth factors by an induction of gene transcription. Elements within these genes that respond to serum and the trans-acting proteins that bind to these regions have been identified and isolated [66] . Whether the LDL receptor gene contains similar serum-responsive elements is unknown.
The tissue specificity of the serum-mediated effect on Hep-G2 cells is also of interest. In cultured fibroblasts, the addition of whole serum, and certainly the addition of serum plus the d < 1.063 fraction of serum, decreases rather than increases the number of LDL receptors. Thus the effect on LDL receptors in Hep-G2 cells is somewhat unique to this liver-derived tissue. Others have noted sluggish down-regulation of LDL receptors by exogenous LDL in liver-derived cells. Whereas incubation of fibroblasts with as little as 20-40 ,ug of LDL protein/ml for 24 h results in a 75-85 % decrease in LDL binding [33, 42] , incubation of pig [37] , rat [38] or human [39] [40] [41] hepatocytes or Hep-G2 cells [33] [34] [35] [36] with 100-200,ug of LDL protein/ml for 24-48 h decreased LDL receptor activity by only %. These findings are not limited to studies of LDL receptor activity in cultured cells, since the hepatic catabolism of LDL in vivo in rats [67] and hamsters [68] , whose serum level of LDL was elevated 6-10-fold by a constant infusion of LDL, was only partially downregulated. Interestingly, the clearance of LDL by the adrenal gland was decreased to a greater extent than transport by the liver at comparable serum LDL concentrations [68] . The residual hepatic clearance of LDL observed in these studies was not due solely to LDL-receptor-independent transport since, at the maximum serum LDL concentration employed, the hepatic LDL-receptor-mediated clearance of LDL was 6-8 times that of methylated-LDL [68] . Similar observations have been made by Nenseter et al. [69] who reported that, although the uptake of LDL by hepatic parenchymal cells of rabbits was decreased by 70 % by feeding a cholesterol-rich diet, the clearance of LDL by hepatocytes was still 2-3 times that of methylated-LDL. A relative insensitivity of hepatic LDL receptor activity to dietary cholesterol was also observed by Reagan et al. [70] , who found that, despite a greater than 90% decrease in hepatic sterol synthesis, there was no significant decrease in LDL-receptormediated clearance of '251-tyramine cellobiose-LDL by the liver in pigeons fed a cholesterol-rich diet. Taken together, these studies indicate that receptor-mediated transport of LDL by the liver is relatively insensitive to the serum concentration of LDL cholesterol. Since the liver is exposed to physiological concentrations of LDL in vivo, LDL transport in the face of saturating concentrations of LDL may be indicative of sterol-independent regulation of hepatic LDL receptor activity. Defining the mechanism for such regulation will be of considerable importance in understanding those factors that govern the plasma level of LDL cholesterol.
